Industry Research Reports

Home > Reports > Pharma & Healthcare > Global Opioid Induced Constipation (OIC) Drugs Market Report, History and Forecast 2018-2029, Breakdown Data by Manufacturers, Key Regions, Types and Application

Global Opioid Induced Constipation (OIC) Drugs Market Report, History and Forecast 2018-2029, Breakdown Data by Manufacturers, Key Regions, Types and Application

Industry: Pharma & Healthcare

Published: 2023-05-31

Pages: 113 Pages

Report ld: 1283748

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Although opioids are very effective for treating and managing pain, their use frequently results in opioid-induced constipation (OIC). Treatment options for OIC may be as simple as changing diet or as complicated as requiring several medicines and laxatives.

Opioid Induced Constipation (OIC) Drugs report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Opioid Induced Constipation (OIC) Drugs market is projected to reach US$ 3490.4 million in 2029, increasing from US$ 2531 million in 2022, with the CAGR of 4.6% during the period of 2023 to 2029. Demand from Hospital Pharmacies and Retail Pharmacies are the major drivers for the industry.

Global Opioid-Induced Constipation key players include Sanofi, Bayer, Purdue Pharm, etc. Global top three manufacturers hold a share over 45%.

North America is the largest market, with a share about 55%, followed by Europe, and Asia-Pacific, both have a share about 35 percent.
In terms of product, Lubiprostone is the largest segment, with a share about 5%. And in terms of application, the largest application is Pharmacy, followed by Hospital, etc.

Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Opioid Induced Constipation (OIC) Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Manufacturers, Type, Application and Regions Listed in the Report:
By Company
Ironwood Pharmaceuticals Inc
Daiichi Sankyo Co Ltd
Pfizer
Progenics Pharmaceuticals Inc
Shionogi & Co., Ltd
Allergan Plc
Nektar Therapeutics
Purdue Pharma
S.L.A. Pharma AG
Mundipharma International Limited
Ono Pharmaceutical Co., Ltd
Takeda Pharmaceutical Company Limited
Theravance Biopharma Inc
Bausch Health
Cosmo Pharmaceuticals SA
Daewoong Pharmaceutical
C.B. Fleet Company
Sucampo Pharmaceuticals

Segment by Type
Lubiprostone
Methyl Naltrexone Bromide
Naldemedine
Alvimopan
Others

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

Each chapter of the report provides detailed information for readers to understand the Opioid Induced Constipation (OIC) Drugs market further:
Chapter 1: Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 2: Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Opioid Induced Constipation (OIC) Drugs, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Opioid Induced Constipation (OIC) Drugs industry.
Chapter 3: Historical (2018-2022) and forecast (2023-2029) volume and revenue analysis of Opioid Induced Constipation (OIC) Drugs in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4: Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 5 to 9: Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10: Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Opioid Induced Constipation (OIC) Drugs introduction, etc. Opioid Induced Constipation (OIC) Drugs Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11: Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12: Market Channel, Distributors and Customers are listed.
Chapter 13: QYResearch’s Conclusions of Opioid Induced Constipation (OIC) Drugs market based on comprehensive survey.
Chapter 14: Methodology and Data Sources adopted by QYResearch.

 1 Opioid Induced Constipation (OIC) Drugs Market Overview
    1.1 Opioid Induced Constipation (OIC) Drugs Product Overview
    1.2 Opioid Induced Constipation (OIC) Drugs Market Segment by Type
        1.2.1 Lubiprostone
        1.2.2 Methyl Naltrexone Bromide
        1.2.3 Naldemedine
        1.2.4 Alvimopan
        1.2.5 Others
    1.3 Global Opioid Induced Constipation (OIC) Drugs Market Size by Type
        1.3.1 Global Opioid Induced Constipation (OIC) Drugs Market Size Overview by Type (2018-2029)
        1.3.2 Global Opioid Induced Constipation (OIC) Drugs Historic Market Size Review by Type (2018-2023)
        1.3.3 Global Opioid Induced Constipation (OIC) Drugs Forecasted Market Size by Type (2024-2029)
    1.4 Key Regions Market Size Segment by Type
        1.4.1 North America Opioid Induced Constipation (OIC) Drugs Sales Breakdown by Type (2018-2023)
        1.4.2 Europe Opioid Induced Constipation (OIC) Drugs Sales Breakdown by Type (2018-2023)
        1.4.3 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Breakdown by Type (2018-2023)
        1.4.4 Latin America Opioid Induced Constipation (OIC) Drugs Sales Breakdown by Type (2018-2023)
        1.4.5 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales Breakdown by Type (2018-2023)

 2 Global Opioid Induced Constipation (OIC) Drugs Market Competition by Company
    2.1 Global Top Players by Opioid Induced Constipation (OIC) Drugs Sales (2018-2023)
    2.2 Global Top Players by Opioid Induced Constipation (OIC) Drugs Revenue (2018-2023)
    2.3 Global Top Players by Opioid Induced Constipation (OIC) Drugs Price (2018-2023)
    2.4 Global Top Manufacturers Opioid Induced Constipation (OIC) Drugs Manufacturing Base Distribution, Sales Area, Product Type
    2.5 Opioid Induced Constipation (OIC) Drugs Market Competitive Situation and Trends
        2.5.1 Opioid Induced Constipation (OIC) Drugs Market Concentration Rate (2018-2023)
        2.5.2 Global 5 and 10 Largest Manufacturers by Opioid Induced Constipation (OIC) Drugs Sales and Revenue in 2022
    2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Opioid Induced Constipation (OIC) Drugs as of 2022)
    2.7 Date of Key Manufacturers Enter into Opioid Induced Constipation (OIC) Drugs Market
    2.8 Key Manufacturers Opioid Induced Constipation (OIC) Drugs Product Offered
    2.9 Mergers & Acquisitions, Expansion

 3 Opioid Induced Constipation (OIC) Drugs Status and Outlook by Region
    3.1 Global Opioid Induced Constipation (OIC) Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2029
    3.2 Global Opioid Induced Constipation (OIC) Drugs Historic Market Size by Region
        3.2.1 Global Opioid Induced Constipation (OIC) Drugs Sales in Volume by Region (2018-2023)
        3.2.2 Global Opioid Induced Constipation (OIC) Drugs Sales in Value by Region (2018-2023)
        3.2.3 Global Opioid Induced Constipation (OIC) Drugs Sales (Volume & Value) Price and Gross Margin (2018-2023)
    3.3 Global Opioid Induced Constipation (OIC) Drugs Forecasted Market Size by Region
        3.3.1 Global Opioid Induced Constipation (OIC) Drugs Sales in Volume by Region (2024-2029)
        3.3.2 Global Opioid Induced Constipation (OIC) Drugs Sales in Value by Region (2024-2029)
        3.3.3 Global Opioid Induced Constipation (OIC) Drugs Sales (Volume & Value), Price and Gross Margin (2024-2029)

 4 Global Opioid Induced Constipation (OIC) Drugs by Application
    4.1 Opioid Induced Constipation (OIC) Drugs Market Segment by Application
        4.1.1 Hospital Pharmacies
        4.1.2 Retail Pharmacies
        4.1.3 Online Pharmacies
    4.2 Global Opioid Induced Constipation (OIC) Drugs Market Size by Application
        4.2.1 Global Opioid Induced Constipation (OIC) Drugs Market Size Overview by Application (2018-2029)
        4.2.2 Global Opioid Induced Constipation (OIC) Drugs Historic Market Size Review by Application (2018-2023)
        4.2.3 Global Opioid Induced Constipation (OIC) Drugs Forecasted Market Size by Application (2024-2029)
    4.3 Key Regions Market Size Segment by Application
        4.3.1 North America Opioid Induced Constipation (OIC) Drugs Sales Breakdown by Application (2018-2023)
        4.3.2 Europe Opioid Induced Constipation (OIC) Drugs Sales Breakdown by Application (2018-2023)
        4.3.3 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Breakdown by Application (2018-2023)
        4.3.4 Latin America Opioid Induced Constipation (OIC) Drugs Sales Breakdown by Application (2018-2023)
        4.3.5 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales Breakdown by Application (2018-2023)

 5 North America Opioid Induced Constipation (OIC) Drugs by Country
    5.1 North America Opioid Induced Constipation (OIC) Drugs Historic Market Size by Country
        5.1.1 North America Opioid Induced Constipation (OIC) Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
        5.1.2 North America Opioid Induced Constipation (OIC) Drugs Sales in Volume by Country (2018-2023)
        5.1.3 North America Opioid Induced Constipation (OIC) Drugs Sales in Value by Country (2018-2023)
    5.2 North America Opioid Induced Constipation (OIC) Drugs Forecasted Market Size by Country
        5.2.1 North America Opioid Induced Constipation (OIC) Drugs Sales in Volume by Country (2024-2029)
        5.2.2 North America Opioid Induced Constipation (OIC) Drugs Sales in Value by Country (2024-2029)

 6 Europe Opioid Induced Constipation (OIC) Drugs by Country
    6.1 Europe Opioid Induced Constipation (OIC) Drugs Historic Market Size by Country
        6.1.1 Europe Opioid Induced Constipation (OIC) Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
        6.1.2 Europe Opioid Induced Constipation (OIC) Drugs Sales in Volume by Country (2018-2023)
        6.1.3 Europe Opioid Induced Constipation (OIC) Drugs Sales in Value by Country (2018-2023)
    6.2 Europe Opioid Induced Constipation (OIC) Drugs Forecasted Market Size by Country
        6.2.1 Europe Opioid Induced Constipation (OIC) Drugs Sales in Volume by Country (2024-2029)
        6.2.2 Europe Opioid Induced Constipation (OIC) Drugs Sales in Value by Country (2024-2029)

 7 Asia-Pacific Opioid Induced Constipation (OIC) Drugs by Region
    7.1 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Historic Market Size by Region
        7.1.1 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
        7.1.2 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales in Volume by Region (2018-2023)
        7.1.3 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales in Value by Region (2018-2023)
    7.2 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Forecasted Market Size by Region
        7.2.1 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales in Volume by Region (2024-2029)
        7.2.2 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales in Value by Region (2024-2029)

 8 Latin America Opioid Induced Constipation (OIC) Drugs by Country
    8.1 Latin America Opioid Induced Constipation (OIC) Drugs Historic Market Size by Country
        8.1.1 Latin America Opioid Induced Constipation (OIC) Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
        8.1.2 Latin America Opioid Induced Constipation (OIC) Drugs Sales in Volume by Country (2018-2023)
        8.1.3 Latin America Opioid Induced Constipation (OIC) Drugs Sales in Value by Country (2018-2023)
    8.2 Latin America Opioid Induced Constipation (OIC) Drugs Forecasted Market Size by Country
        8.2.1 Latin America Opioid Induced Constipation (OIC) Drugs Sales in Volume by Country (2024-2029)
        8.2.2 Latin America Opioid Induced Constipation (OIC) Drugs Sales in Value by Country (2024-2029)

 9 Middle East and Africa Opioid Induced Constipation (OIC) Drugs by Country
    9.1 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Historic Market Size by Country
        9.1.1 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
        9.1.2 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales in Volume by Country (2018-2023)
        9.1.3 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales in Value by Country (2018-2023)
    9.2 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Forecasted Market Size by Country
        9.2.1 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales in Volume by Country (2024-2029)
        9.2.2 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales in Value by Country (2024-2029)

 10 Company Profiles
    10.1 Ironwood Pharmaceuticals Inc
        10.1.1 Ironwood Pharmaceuticals Inc Company Information
        10.1.2 Ironwood Pharmaceuticals Inc Introduction and Business Overview
        10.1.3 Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2018-2023)
        10.1.4 Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Products Offered
        10.1.5 Ironwood Pharmaceuticals Inc Recent Development
    10.2 Daiichi Sankyo Co Ltd
        10.2.1 Daiichi Sankyo Co Ltd Company Information
        10.2.2 Daiichi Sankyo Co Ltd Introduction and Business Overview
        10.2.3 Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2018-2023)
        10.2.4 Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Products Offered
        10.2.5 Daiichi Sankyo Co Ltd Recent Development
    10.3 Pfizer
        10.3.1 Pfizer Company Information
        10.3.2 Pfizer Introduction and Business Overview
        10.3.3 Pfizer Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2018-2023)
        10.3.4 Pfizer Opioid Induced Constipation (OIC) Drugs Products Offered
        10.3.5 Pfizer Recent Development
    10.4 Progenics Pharmaceuticals Inc
        10.4.1 Progenics Pharmaceuticals Inc Company Information
        10.4.2 Progenics Pharmaceuticals Inc Introduction and Business Overview
        10.4.3 Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2018-2023)
        10.4.4 Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Products Offered
        10.4.5 Progenics Pharmaceuticals Inc Recent Development
    10.5 Shionogi & Co., Ltd
        10.5.1 Shionogi & Co., Ltd Company Information
        10.5.2 Shionogi & Co., Ltd Introduction and Business Overview
        10.5.3 Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2018-2023)
        10.5.4 Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Products Offered
        10.5.5 Shionogi & Co., Ltd Recent Development
    10.6 Allergan Plc
        10.6.1 Allergan Plc Company Information
        10.6.2 Allergan Plc Introduction and Business Overview
        10.6.3 Allergan Plc Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2018-2023)
        10.6.4 Allergan Plc Opioid Induced Constipation (OIC) Drugs Products Offered
        10.6.5 Allergan Plc Recent Development
    10.7 Nektar Therapeutics
        10.7.1 Nektar Therapeutics Company Information
        10.7.2 Nektar Therapeutics Introduction and Business Overview
        10.7.3 Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2018-2023)
        10.7.4 Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Products Offered
        10.7.5 Nektar Therapeutics Recent Development
    10.8 Purdue Pharma
        10.8.1 Purdue Pharma Company Information
        10.8.2 Purdue Pharma Introduction and Business Overview
        10.8.3 Purdue Pharma Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2018-2023)
        10.8.4 Purdue Pharma Opioid Induced Constipation (OIC) Drugs Products Offered
        10.8.5 Purdue Pharma Recent Development
    10.9 S.L.A. Pharma AG
        10.9.1 S.L.A. Pharma AG Company Information
        10.9.2 S.L.A. Pharma AG Introduction and Business Overview
        10.9.3 S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2018-2023)
        10.9.4 S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Products Offered
        10.9.5 S.L.A. Pharma AG Recent Development
    10.10 Mundipharma International Limited
        10.10.1 Mundipharma International Limited Company Information
        10.10.2 Mundipharma International Limited Introduction and Business Overview
        10.10.3 Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2018-2023)
        10.10.4 Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Products Offered
        10.10.5 Mundipharma International Limited Recent Development
    10.11 Ono Pharmaceutical Co., Ltd
        10.11.1 Ono Pharmaceutical Co., Ltd Company Information
        10.11.2 Ono Pharmaceutical Co., Ltd Introduction and Business Overview
        10.11.3 Ono Pharmaceutical Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2018-2023)
        10.11.4 Ono Pharmaceutical Co., Ltd Opioid Induced Constipation (OIC) Drugs Products Offered
        10.11.5 Ono Pharmaceutical Co., Ltd Recent Development
    10.12 Takeda Pharmaceutical Company Limited
        10.12.1 Takeda Pharmaceutical Company Limited Company Information
        10.12.2 Takeda Pharmaceutical Company Limited Introduction and Business Overview
        10.12.3 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2018-2023)
        10.12.4 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drugs Products Offered
        10.12.5 Takeda Pharmaceutical Company Limited Recent Development
    10.13 Theravance Biopharma Inc
        10.13.1 Theravance Biopharma Inc Company Information
        10.13.2 Theravance Biopharma Inc Introduction and Business Overview
        10.13.3 Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2018-2023)
        10.13.4 Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Products Offered
        10.13.5 Theravance Biopharma Inc Recent Development
    10.14 Bausch Health
        10.14.1 Bausch Health Company Information
        10.14.2 Bausch Health Introduction and Business Overview
        10.14.3 Bausch Health Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2018-2023)
        10.14.4 Bausch Health Opioid Induced Constipation (OIC) Drugs Products Offered
        10.14.5 Bausch Health Recent Development
    10.15 Cosmo Pharmaceuticals SA
        10.15.1 Cosmo Pharmaceuticals SA Company Information
        10.15.2 Cosmo Pharmaceuticals SA Introduction and Business Overview
        10.15.3 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2018-2023)
        10.15.4 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drugs Products Offered
        10.15.5 Cosmo Pharmaceuticals SA Recent Development
    10.16 Daewoong Pharmaceutical
        10.16.1 Daewoong Pharmaceutical Company Information
        10.16.2 Daewoong Pharmaceutical Introduction and Business Overview
        10.16.3 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2018-2023)
        10.16.4 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drugs Products Offered
        10.16.5 Daewoong Pharmaceutical Recent Development
    10.17 C.B. Fleet Company
        10.17.1 C.B. Fleet Company Company Information
        10.17.2 C.B. Fleet Company Introduction and Business Overview
        10.17.3 C.B. Fleet Company Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2018-2023)
        10.17.4 C.B. Fleet Company Opioid Induced Constipation (OIC) Drugs Products Offered
        10.17.5 C.B. Fleet Company Recent Development
    10.18 Sucampo Pharmaceuticals
        10.18.1 Sucampo Pharmaceuticals Company Information
        10.18.2 Sucampo Pharmaceuticals Introduction and Business Overview
        10.18.3 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2018-2023)
        10.18.4 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Products Offered
        10.18.5 Sucampo Pharmaceuticals Recent Development

 11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
    11.1 Opioid Induced Constipation (OIC) Drugs Key Raw Materials
        11.1.1 Key Raw Materials
        11.1.2 Key Raw Materials Price
        11.1.3 Raw Materials Key Suppliers
    11.2 Manufacturing Cost Structure
        11.2.1 Raw Materials
        11.2.2 Labor Cost
        11.2.3 Manufacturing Expenses
    11.3 Opioid Induced Constipation (OIC) Drugs Industrial Chain Analysis
    11.4 Opioid Induced Constipation (OIC) Drugs Market Dynamics
        11.4.1 Opioid Induced Constipation (OIC) Drugs Industry Trends
        11.4.2 Opioid Induced Constipation (OIC) Drugs Market Drivers
        11.4.3 Opioid Induced Constipation (OIC) Drugs Market Challenges
        11.4.4 Opioid Induced Constipation (OIC) Drugs Market Restraints

 12 Market Strategy Analysis, Distributors
    12.1 Sales Channel
    12.2 Opioid Induced Constipation (OIC) Drugs Distributors
    12.3 Opioid Induced Constipation (OIC) Drugs Downstream Customers

 13 Research Findings and Conclusion

 14 Appendix
    14.1 Research Methodology
        14.1.1 Methodology/Research Approach
        14.1.2 Data Source
    14.2 Author Details
    14.3 Disclaimer

List of Tables
    Table 1. Major Company of Lubiprostone
    Table 2. Major Company of Methyl Naltrexone Bromide
    Table 3. Major Company of Naldemedine
    Table 4. Major Company of Alvimopan
    Table 5. Major Company of Others
    Table 6. Global Opioid Induced Constipation (OIC) Drugs Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
    Table 7. Global Opioid Induced Constipation (OIC) Drugs Sales by Type (2018-2023) & (K Dose)
    Table 8. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share in Volume by Type (2018-2023)
    Table 9. Global Opioid Induced Constipation (OIC) Drugs Sales by Type (2018-2023) & (US& Million)
    Table 10. Global Opioid Induced Constipation (OIC) Drugs Market Share in Value by Type (2018-2023)
    Table 11. Global Opioid Induced Constipation (OIC) Drugs Price by Type (2018-2023) & (USD/Dose)
    Table 12. Global Opioid Induced Constipation (OIC) Drugs Sales by Type (2024-2029) & (K Dose)
    Table 13. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share in Volume by Type (2024-2029)
    Table 14. Global Opioid Induced Constipation (OIC) Drugs Sales by Type (2024-2029) & (US$ Million)
    Table 15. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share in Value by Type (2024-2029)
    Table 16. Global Opioid Induced Constipation (OIC) Drugs Price by Type (2024-2029) & (USD/Dose)
    Table 17. North America Opioid Induced Constipation (OIC) Drugs Sales by Type (2018-2023) & (K Dose)
    Table 18. North America Opioid Induced Constipation (OIC) Drugs Sales by Type (2018-2023) & (US$ Million)
    Table 19. Europe Opioid Induced Constipation (OIC) Drugs Sales (K Dose) by Type (2018-2023)
    Table 20. Europe Opioid Induced Constipation (OIC) Drugs Sales by Type (2018-2023) & (US$ Million)
    Table 21. Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales (K Dose) by Type (2018-2023)
    Table 22. Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales by Type (2018-2023) & (US$ Million)
    Table 23. Latin America Opioid Induced Constipation (OIC) Drugs Sales (K Dose) by Type (2018-2023)
    Table 24. Latin America Opioid Induced Constipation (OIC) Drugs Sales by Type (2018-2023) & (US$ Million)
    Table 25. Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales (K Dose) by Type (2018-2023)
    Table 26. Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales by Type (2018-2023) & (US$ Million)
    Table 27. Global Opioid Induced Constipation (OIC) Drugs Sales by Company (2018-2023) & (K Dose)
    Table 28. Global Opioid Induced Constipation (OIC) Drugs Sales Share by Company (2018-2023)
    Table 29. Global Opioid Induced Constipation (OIC) Drugs Revenue by Company (2018-2023) & (US$ Million)
    Table 30. Global Opioid Induced Constipation (OIC) Drugs Revenue Share by Company (2018-2023)
    Table 31. Global Market Opioid Induced Constipation (OIC) Drugs Price by Company (2018-2023) & (USD/Dose)
    Table 32. Global Opioid Induced Constipation (OIC) Drugs Top Manufacturers Manufacturing Base Distribution and Sales Area
    Table 33. Global Opioid Induced Constipation (OIC) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 34. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Opioid Induced Constipation (OIC) Drugs as of 2022)
    Table 35. Date of Key Manufacturers Enter into Opioid Induced Constipation (OIC) Drugs Market
    Table 36. Key Manufacturers Opioid Induced Constipation (OIC) Drugs Product Type
    Table 37. Mergers & Acquisitions, Expansion Plans
    Table 38. Global Opioid Induced Constipation (OIC) Drugs Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 39. Global Opioid Induced Constipation (OIC) Drugs Sales by Region (2018-2023) & (K Dose)
    Table 40. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share in Volume by Region (2018-2023)
    Table 41. Global Opioid Induced Constipation (OIC) Drugs Sales by Region (2018-2023) & (US$ Million)
    Table 42. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share in Value by Region (2018-2023)
    Table 43. Global Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)
    Table 44. Global Opioid Induced Constipation (OIC) Drugs Sales by Region (2024-2029) & (K Dose)
    Table 45. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share in Volume by Region (2024-2029)
    Table 46. Global Opioid Induced Constipation (OIC) Drugs Sales by Region (2024-2029) & (US$ Million)
    Table 47. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share in Value by Region (2024-2029)
    Table 48. Global Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2024-2029)
    Table 49. Global Opioid Induced Constipation (OIC) Drugs Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 50. Global Opioid Induced Constipation (OIC) Drugs Sales by Application (2018-2023) & (K Dose)
    Table 51. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share in Volume by Application (2018-2023)
    Table 52. Global Opioid Induced Constipation (OIC) Drugs Sales by Application (2018-2023) & (US$ Million)
    Table 53. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share in Value by Application (2018-2023)
    Table 54. Global Opioid Induced Constipation (OIC) Drugs Price by Application (2018-2023) & (USD/Dose)
    Table 55. Global Opioid Induced Constipation (OIC) Drugs Sales by Application (2024-2029) & (K Dose)
    Table 56. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share in Volume by Application (2024-2029)
    Table 57. Global Opioid Induced Constipation (OIC) Drugs Sales by Application (2024-2029) & (US$ Million)
    Table 58. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share in Value by Application (2024-2029)
    Table 59. Global Opioid Induced Constipation (OIC) Drugs Price by Application (2024-2029) & (USD/Dose)
    Table 60. North America Opioid Induced Constipation (OIC) Drugs Sales by Application (2018-2023) (K Dose) 
    Table 61. North America Opioid Induced Constipation (OIC) Drugs Sales by Application (2018-2023) & (US$ Million)
    Table 62. Europe Opioid Induced Constipation (OIC) Drugs Sales by Application (2018-2023) (K Dose) 
    Table 63. Europe Opioid Induced Constipation (OIC) Drugs Sales by Application (2018-2023) & (US$ Million)
    Table 64. Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales by Application (2018-2023) (K Dose) 
    Table 65. Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales by Application (2018-2023) & (US$ Million)
    Table 66. Latin America Opioid Induced Constipation (OIC) Drugs Sales by Application (2018-2023) (K Dose) 
    Table 67. Latin America Opioid Induced Constipation (OIC) Drugs Sales by Application (2018-2023) & (US$ Million)
    Table 68. Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales by Application (2018-2023) (K Dose) 
    Table 69. Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales by Application (2018-2023) & (US$ Million)
    Table 70. North America Opioid Induced Constipation (OIC) Drugs Sales by Country (2018-2023) & (K Dose)
    Table 71. North America Opioid Induced Constipation (OIC) Drugs Sales Market Share in Volume by Country (2018-2023)
    Table 72. North America Opioid Induced Constipation (OIC) Drugs Sales by Country (2018-2023) & (US$ Million)
    Table 73. North America Opioid Induced Constipation (OIC) Drugs Sales Market Share in Value by Country (2018-2023)
    Table 74. North America Opioid Induced Constipation (OIC) Drugs Sales by Country (2024-2029) & (K Dose)
    Table 75. North America Opioid Induced Constipation (OIC) Drugs Sales Market Share in Volume by Country (2024-2029)
    Table 76. North America Opioid Induced Constipation (OIC) Drugs Sales by Country (2024-2029) & (US$ Million)
    Table 77. North America Opioid Induced Constipation (OIC) Drugs Sales Market Share in Value by Country (2024-2029)
    Table 78. Europe Opioid Induced Constipation (OIC) Drugs Sales by Country (2018-2023) & (K Dose)
    Table 79. Europe Opioid Induced Constipation (OIC) Drugs Sales Market Share in Volume by Country (2018-2023)
    Table 80. Europe Opioid Induced Constipation (OIC) Drugs Sales by Country (2018-2023) & (US$ Million)
    Table 81. Europe Opioid Induced Constipation (OIC) Drugs Sales Market Share in Value by Country (2018-2023)
    Table 82. Europe Opioid Induced Constipation (OIC) Drugs Sales by Country (2024-2029) & (K Dose)
    Table 83. Europe Opioid Induced Constipation (OIC) Drugs Sales Market Share in Volume by Country (2024-2029)
    Table 84. Europe Opioid Induced Constipation (OIC) Drugs Sales by Country (2024-2029) & (US$ Million)
    Table 85. Europe Opioid Induced Constipation (OIC) Drugs Sales Market Share in Value by Country (2024-2029)
    Table 86. Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales by Region (2018-2023) & (K Dose)
    Table 87. Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Market Share in Volume by Region (2018-2023)
    Table 88. Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales by Region (2018-2023) & (US$ Million)
    Table 89. Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Market Share in Value by Region (2018-2023)
    Table 90. Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales by Region (2024-2029) & (K Dose)
    Table 91. Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Market Share in Volume by Region (2024-2029)
    Table 92. Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales by Region (2024-2029) & (US$ Million)
    Table 93. Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Market Share in Value by Region (2024-2029)
    Table 94. Latin America Opioid Induced Constipation (OIC) Drugs Sales by Country (2018-2023) & (K Dose)
    Table 95. Latin America Opioid Induced Constipation (OIC) Drugs Sales Market Share in Volume by Country (2018-2023)
    Table 96. Latin America Opioid Induced Constipation (OIC) Drugs Sales by Country (2018-2023) & (US$ Million)
    Table 97. Latin America Opioid Induced Constipation (OIC) Drugs Sales Market Share in Value by Country (2018-2023)
    Table 98. Latin America Opioid Induced Constipation (OIC) Drugs Sales by Country (2024-2029) & (K Dose)
    Table 99. Latin America Opioid Induced Constipation (OIC) Drugs Sales Market Share in Volume by Country (2024-2029)
    Table 100. Latin America Opioid Induced Constipation (OIC) Drugs Sales by Country (2024-2029) & (US$ Million)
    Table 101. Latin America Opioid Induced Constipation (OIC) Drugs Sales Market Share in Value by Country (2024-2029)
    Table 102. Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales by Country (2018-2023) & (K Dose)
    Table 103. Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales Market Share in Volume by Country (2018-2023)
    Table 104. Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales by Country (2018-2023) & (US$ Million)
    Table 105. Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales Market Share in Value by Country (2018-2023)
    Table 106. Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales by Country (2024-2029) & (K Dose)
    Table 107. Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales Market Share in Volume by Country (2024-2029)
    Table 108. Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales by Country (2024-2029) & (US$ Million)
    Table 109. Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales Market Share in Value by Country (2024-2029)
    Table 110. Ironwood Pharmaceuticals Inc Company Information
    Table 111. Ironwood Pharmaceuticals Inc Introduction and Business Overview
    Table 112. Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2023)
    Table 113. Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Product
    Table 114. Ironwood Pharmaceuticals Inc Recent Development
    Table 115. Daiichi Sankyo Co Ltd Company Information
    Table 116. Daiichi Sankyo Co Ltd Introduction and Business Overview
    Table 117. Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2023)
    Table 118. Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Product
    Table 119. Daiichi Sankyo Co Ltd Recent Development
    Table 120. Pfizer Company Information
    Table 121. Pfizer Introduction and Business Overview
    Table 122. Pfizer Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2023)
    Table 123. Pfizer Opioid Induced Constipation (OIC) Drugs Product
    Table 124. Pfizer Recent Development
    Table 125. Progenics Pharmaceuticals Inc Company Information
    Table 126. Progenics Pharmaceuticals Inc Introduction and Business Overview
    Table 127. Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2023)
    Table 128. Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Product
    Table 129. Progenics Pharmaceuticals Inc Recent Development
    Table 130. Shionogi & Co., Ltd Company Information
    Table 131. Shionogi & Co., Ltd Introduction and Business Overview
    Table 132. Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2023)
    Table 133. Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Product
    Table 134. Shionogi & Co., Ltd Recent Development
    Table 135. Allergan Plc Company Information
    Table 136. Allergan Plc Introduction and Business Overview
    Table 137. Allergan Plc Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2023)
    Table 138. Allergan Plc Opioid Induced Constipation (OIC) Drugs Product
    Table 139. Allergan Plc Recent Development
    Table 140. Nektar Therapeutics Company Information
    Table 141. Nektar Therapeutics Introduction and Business Overview
    Table 142. Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2023)
    Table 143. Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Product
    Table 144. Nektar Therapeutics Recent Development
    Table 145. Purdue Pharma Company Information
    Table 146. Purdue Pharma Introduction and Business Overview
    Table 147. Purdue Pharma Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2023)
    Table 148. Purdue Pharma Opioid Induced Constipation (OIC) Drugs Product
    Table 149. Purdue Pharma Recent Development
    Table 150. S.L.A. Pharma AG Company Information
    Table 151. S.L.A. Pharma AG Introduction and Business Overview
    Table 152. S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2023)
    Table 153. S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Product
    Table 154. S.L.A. Pharma AG Recent Development
    Table 155. Mundipharma International Limited Company Information
    Table 156. Mundipharma International Limited Introduction and Business Overview
    Table 157. Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2023)
    Table 158. Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Product
    Table 159. Mundipharma International Limited Recent Development
    Table 160. Ono Pharmaceutical Co., Ltd Company Information
    Table 161. Ono Pharmaceutical Co., Ltd Introduction and Business Overview
    Table 162. Ono Pharmaceutical Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2023)
    Table 163. Ono Pharmaceutical Co., Ltd Opioid Induced Constipation (OIC) Drugs Product
    Table 164. Ono Pharmaceutical Co., Ltd Recent Development
    Table 165. Takeda Pharmaceutical Company Limited Company Information
    Table 166. Takeda Pharmaceutical Company Limited Introduction and Business Overview
    Table 167. Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2023)
    Table 168. Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drugs Product
    Table 169. Takeda Pharmaceutical Company Limited Recent Development
    Table 170. Theravance Biopharma Inc Company Information
    Table 171. Theravance Biopharma Inc Introduction and Business Overview
    Table 172. Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2023)
    Table 173. Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Product
    Table 174. Theravance Biopharma Inc Recent Development
    Table 175. Bausch Health Company Information
    Table 176. Bausch Health Introduction and Business Overview
    Table 177. Bausch Health Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2023)
    Table 178. Bausch Health Opioid Induced Constipation (OIC) Drugs Product
    Table 179. Bausch Health Recent Development
    Table 180. Cosmo Pharmaceuticals SA Company Information
    Table 181. Cosmo Pharmaceuticals SA Introduction and Business Overview
    Table 182. Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2023)
    Table 183. Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drugs Product
    Table 184. Cosmo Pharmaceuticals SA Recent Development
    Table 185. Daewoong Pharmaceutical Company Information
    Table 186. Daewoong Pharmaceutical Introduction and Business Overview
    Table 187. Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2023)
    Table 188. Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drugs Product
    Table 189. Daewoong Pharmaceutical Recent Development
    Table 190. C.B. Fleet Company Company Information
    Table 191. C.B. Fleet Company Introduction and Business Overview
    Table 192. C.B. Fleet Company Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2023)
    Table 193. C.B. Fleet Company Opioid Induced Constipation (OIC) Drugs Product
    Table 194. C.B. Fleet Company Recent Development
    Table 195. Sucampo Pharmaceuticals Company Information
    Table 196. Sucampo Pharmaceuticals Introduction and Business Overview
    Table 197. Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2023)
    Table 198. Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Product
    Table 199. Sucampo Pharmaceuticals Recent Development
    Table 200. Key Raw Materials Lists
    Table 201. Raw Materials Key Suppliers Lists
    Table 202. Opioid Induced Constipation (OIC) Drugs Market Trends
    Table 203. Opioid Induced Constipation (OIC) Drugs Market Drivers
    Table 204. Opioid Induced Constipation (OIC) Drugs Market Challenges
    Table 205. Opioid Induced Constipation (OIC) Drugs Market Restraints
    Table 206. Opioid Induced Constipation (OIC) Drugs Distributors List
    Table 207. Opioid Induced Constipation (OIC) Drugs Downstream Customers
    Table 208. Research Programs/Design for This Report
    Table 209. Key Data Information from Secondary Sources
    Table 210. Key Data Information from Primary Sources
List of Figures
    Figure 1. Opioid Induced Constipation (OIC) Drugs Product Picture
    Figure 2. Global Opioid Induced Constipation (OIC) Drugs Market Size, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 3. Global Opioid Induced Constipation (OIC) Drugs Market Size Status and Outlook (2018-2029) & (US$ Million)
    Figure 4. Global Opioid Induced Constipation (OIC) Drugs Sales Status and Outlook (2018-2029) & (K Dose)
    Figure 5. Product Picture of Lubiprostone
    Figure 6. Global Lubiprostone Sales YoY Growth (2018-2029) & (K Dose)
    Figure 7. Product Picture of Methyl Naltrexone Bromide
    Figure 8. Global Methyl Naltrexone Bromide Sales YoY Growth (2018-2029) & (K Dose)
    Figure 9. Product Picture of Naldemedine
    Figure 10. Global Naldemedine Sales YoY Growth (2018-2029) & (K Dose)
    Figure 11. Product Picture of Alvimopan
    Figure 12. Global Alvimopan Sales YoY Growth (2018-2029) & (K Dose)
    Figure 13. Product Picture of Others
    Figure 14. Global Others Sales YoY Growth (2018-2029) & (K Dose)
    Figure 15. Global Opioid Induced Constipation (OIC) Drugs Sales by Type (2018-2029) & (US$ Million)
    Figure 16. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Type in 2022 & 2029
    Figure 17. North America Opioid Induced Constipation (OIC) Drugs Sales Market Share in Volume by Type in 2022
    Figure 18. North America Opioid Induced Constipation (OIC) Drugs Sales Market Share in Value by Type in 2022
    Figure 19. Europe Opioid Induced Constipation (OIC) Drugs Sales Market Share in Volume by Type in 2022
    Figure 20. Europe Opioid Induced Constipation (OIC) Drugs Sales Market Share in Value by Type in 2022
    Figure 21. Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Market Share in Volume by Type in 2022
    Figure 22. Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Market Share in Value by Type in 2022
    Figure 23. Latin America Opioid Induced Constipation (OIC) Drugs Sales Market Share in Volume by Type in 2022
    Figure 24. Latin America Opioid Induced Constipation (OIC) Drugs Sales Market Share in Value by Type in 2022
    Figure 25. Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales Market Share in Volume by Type in 2022
    Figure 26. Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales Market Share in Value by Type in 2022
    Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Opioid Induced Constipation (OIC) Drugs Sales in 2022
    Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by Opioid Induced Constipation (OIC) Drugs Revenue in 2022
    Figure 29. Opioid Induced Constipation (OIC) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
    Figure 30. Product Picture of Hospital Pharmacies
    Figure 31. Global Hospital Pharmacies Sales YoY Growth (2018-2029) & (K Dose)
    Figure 32. Product Picture of Retail Pharmacies
    Figure 33. Global Retail Pharmacies Sales YoY Growth (2018-2029) & (K Dose)
    Figure 34. Product Picture of Online Pharmacies
    Figure 35. Global Online Pharmacies Sales YoY Growth (2018-2029) & (K Dose)
    Figure 36. Global Opioid Induced Constipation (OIC) Drugs Sales by Application (2018-2029) & (US$ Million)
    Figure 37. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Application in 2022 & 2029
    Figure 38. North America Opioid Induced Constipation (OIC) Drugs Sales Market Share in Volume by Application in 2022
    Figure 39. North America Opioid Induced Constipation (OIC) Drugs Sales Market Share in Value by Application in 2022
    Figure 40. Europe Opioid Induced Constipation (OIC) Drugs Sales Market Share in Volume by Application in 2022
    Figure 41. Europe Opioid Induced Constipation (OIC) Drugs Sales Market Share in Value by Application in 2022
    Figure 42. Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Market Share in Volume by Application in 2022
    Figure 43. Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Market Share in Value by Application in 2022
    Figure 44. Latin America Opioid Induced Constipation (OIC) Drugs Sales Market Share in Volume by Application in 2022
    Figure 45. Latin America Opioid Induced Constipation (OIC) Drugs Sales Market Share in Value by Application in 2022
    Figure 46. Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales Market Share in Value by Application in 2022
    Figure 47. Key Raw Materials Price
    Figure 48. Opioid Induced Constipation (OIC) Drugs Manufacturing Cost Structure
    Figure 49. Opioid Induced Constipation (OIC) Drugs Industrial Chain Analysis
    Figure 50. Channels of Distribution
    Figure 51. Distributors Profiles
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
    Figure 54. Key Executives Interviewed

Although opioids are very effective for treating and managing pain, their use frequently results in opioid-induced constipation (OIC). Treatment options for OIC may be as simple as changing diet or as complicated as requiring several medicines and laxatives.

Opioid Induced Constipation (OIC) Drugs report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Opioid Induced Constipation (OIC) Drugs market is projected to reach US$ 3490.4 million in 2029, increasing from US$ 2531 million in 2022, with the CAGR of 4.6% during the period of 2023 to 2029. Demand from Hospital Pharmacies and Retail Pharmacies are the major drivers for the industry.

Global Opioid-Induced Constipation key players include Sanofi, Bayer, Purdue Pharm, etc. Global top three manufacturers hold a share over 45%.

Segment by Type
Lubiprostone
Methyl Naltrexone Bromide
Naldemedine
Alvimopan
Others

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Industry: Pharma & Healthcare

Published: 2023-05-31

Pages: 113 Pages

Report ld: 1283748

Request Sample

Pre-Order Enquiry

CHOOSE LICENSE TYPE

Single User License

USD 3350.00

Multi Users License

USD 5025.00

Corporate Users License

USD 6700.00

/uploads/payment/payIcon/masterCard-01.svg

/uploads/payment/payIcon/american-express-01.svg

/uploads/payment/payIcon/diners-club-01.svg

/uploads/payment/payIcon/discover-4-01.svg

Add to Cart

Buy Now

A comprehensive and in-depth analysis of current industry data on markets, competitors and suppliers.

In-depth research on key industry players and analysis of production and sales operations.

Objective forecasts of future trends in the industry.

Speak To Our Analyst >>

WHAT QYRESEARCH OFFER?